Last update 22 Nov 2024

SGN-CD48A

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
SGN CD48A
Target
SLAMF2 x Tubulin
Mechanism
SLAMF2 inhibitors(Cluster of differentiation 48 inhibitors), Tubulin inhibitors
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [1]
Active Indication-
Inactive Indication
Multiple Myeloma
Originator Organization
Seagen Inc.Seagen Inc.
Active Organization-
Inactive Organization
Seagen Inc.Seagen Inc.
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC39H67N5O7
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N
CAS Registry474645-27-7

Related

1
Clinical Trials associated with SGN-CD48A
NCT03379584 / TerminatedPhase 1
A Phase 1 Study of SGN-CD48A in Patients With Relapsed or Refractory Multiple Myeloma
100 Clinical Results associated with SGN-CD48A
Login to view more data
100 Translational Medicine associated with SGN-CD48A
Login to view more data
100 Patents (Medical) associated with SGN-CD48A
Login to view more data
100 Deals associated with SGN-CD48A
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 1
US
Seagen Inc.Seagen Inc.
20 Feb 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free